Literature DB >> 23983984

Transdermal patches: the emerging mode of drug delivery system in psychiatry.

Miriam Isaac1, Carl Holvey.   

Abstract

Adherence to prescribed psychiatric and nonpsychiatric medication is a serious issue in people with mental illness that can contribute to poor health outcomes. Some of the factors influencing adherence include side effects of medication and the ease of use. With mental healthcare provision increasingly focusing on a community model of health delivery, there seems to be a renewed interest in addressing complex dilemmas of safety and adherence to treatment. The use of alternative methods of safely delivering medication in innovative ways may resolve some of these difficulties. There has been little discussion about the wider use of transdermal patches in the field of psychiatry in published literature. This article describes the findings from the literature on key principles underlying transdermal delivery strategies, the scope of clinical use in psychiatric illness and explores its challenges and advantages.

Entities:  

Keywords:  Adherence; patches; psychotropics; safety; transdermal

Year:  2012        PMID: 23983984      PMCID: PMC3736952          DOI: 10.1177/2045125312458311

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  29 in total

1.  Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study.

Authors:  N Sacktor; G Schifitto; M P McDermott; K Marder; J C McArthur; K Kieburtz
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 2.  Passive skin penetration enhancement and its quantification in vitro.

Authors:  K Moser; K Kriwet; A Naik; Y N Kalia; R H Guy
Journal:  Eur J Pharm Biopharm       Date:  2001-09       Impact factor: 5.571

3.  Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting.

Authors:  William E Pelham; James G Waxmonsky; Jerome Schentag; Charles H Ballow; Carlos J Panahon; Elizabeth M Gnagy; Martin T Hoffman; Lisa Burrows-MacLean; David L Meichenbaum; Gregory L Forehand; Gregory A Fabiano; Katy E Tresco; Andy Lopez-Williams; Erika K Coles; Mario A González
Journal:  J Atten Disord       Date:  2010-05-03       Impact factor: 3.256

4.  Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systems.

Authors:  J M Gries; N Benowitz; D Verotta
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

5.  Age-related changes in skin permeability of hydrophilic and lipophilic compounds in rats.

Authors:  T Ngawhirunpat; H Yoshikawa; T Hatanaka; T Koizumi; I Adachi
Journal:  Pharmazie       Date:  2001-03       Impact factor: 1.267

6.  The cost-effectiveness of the nicotine transdermal patch for smoking cessation.

Authors:  M A Wasley; S E McNagny; V L Phillips; J S Ahluwalia
Journal:  Prev Med       Date:  1997 Mar-Apr       Impact factor: 4.018

7.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

8.  A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.

Authors:  James J McGough; Sharon B Wigal; Howard Abikoff; John M Turnbow; Kelly Posner; Eliot Moon
Journal:  J Atten Disord       Date:  2006-02       Impact factor: 3.256

9.  Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.

Authors:  Rafael Blesa; Clive Ballard; Jean-Marc Orgogozo; Roger Lane; Simu K Thomas
Journal:  Neurology       Date:  2007-07-24       Impact factor: 9.910

10.  Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation.

Authors:  Ryan K Lanier; Annie Umbricht; Joseph A Harrison; Elie S Nuwayser; George E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2008-03-09       Impact factor: 4.530

View more
  11 in total

1.  Skin Delivery and Irritation Potential of Phenmetrazine as a Candidate Transdermal Formulation for Repurposed Indications.

Authors:  Ying Jiang; Kevin S Murnane; Sonalika A Bhattaccharjee; Bruce E Blough; Ajay K Banga
Journal:  AAPS J       Date:  2019-05-31       Impact factor: 4.009

Review 2.  The Gut Microbiome and Treatment-Resistance in Schizophrenia.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2020-03

3.  The Influence of Solid Microneedles on the Transdermal Delivery of Selected Antiepileptic Drugs.

Authors:  Julia Nguyen; Kevin B Ita; Matthew J Morra; Inna E Popova
Journal:  Pharmaceutics       Date:  2016-11-15       Impact factor: 6.321

Review 4.  Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies.

Authors:  Heather A E Benson; Jeffrey E Grice; Yousuf Mohammed; Sarika Namjoshi; Michael S Roberts
Journal:  Curr Drug Deliv       Date:  2019       Impact factor: 2.565

Review 5.  Delivery of Insulin via Skin Route for the Management of Diabetes Mellitus: Approaches for Breaching the Obstacles.

Authors:  Abdul Ahad; Mohammad Raish; Yousef A Bin Jardan; Abdullah M Al-Mohizea; Fahad I Al-Jenoobi
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

6.  Model-Based Equivalent Dose Optimization to Develop New Donepezil Patch Formulation.

Authors:  Woojin Jung; Heeyoon Jung; Ngoc-Anh Thi Vu; Gwan-Young Kim; Gyoung-Won Kim; Jung-Woo Chae; Taeheon Kim; Hwi-Yeol Yun
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

7.  Experimental Design and Optimization of Nano-Transfersomal Gel to Enhance the Hypoglycemic Activity of Silymarin.

Authors:  Marwa H Abdallah; Amr S Abu Lila; Seham Mohammed Shawky; Khaled Almansour; Farhan Alshammari; El-Sayed Khafagy; Tarek Saad Makram
Journal:  Polymers (Basel)       Date:  2022-01-27       Impact factor: 4.329

Review 8.  Xanthan gum derivatives: review of synthesis, properties and diverse applications.

Authors:  Jwala Patel; Biswajit Maji; N S Hari Narayana Moorthy; Sabyasachi Maiti
Journal:  RSC Adv       Date:  2020-07-21       Impact factor: 4.036

9.  Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study.

Authors:  Nakao Iwata; Jun Ishigooka; Ichiro Naoi; Masahiro Matsumoto; Yuichi Kanamori; Hiroshi Nakamura; Teruhiko Higuchi
Journal:  CNS Drugs       Date:  2020-01       Impact factor: 5.749

10.  Peeking into the future: Transdermal patches for the delivery of micronutrient supplements.

Authors:  Maria G Grammatikopoulou; Konstantinos Gkiouras; Efthimios Dardiotis; Efterpi Zafiriou; Christina Tsigalou; Dimitrios P Bogdanos
Journal:  Metabol Open       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.